MedTrace Logo

Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-III)

NCT05676801 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-05-25

No results posted yet for this study

Summary

The overarching aim of this research project is to prevent orthopedic implant-associated infections. This study aims to investigate if PDT has an effect on bacterial skin colonization in order to improve skin antisepsis strategies for the prevention of surgical site infections.

Conditions

  • Prosthesis and Implants
  • Surgical Site Infection
  • Prosthetic Joint Infection
  • Postoperative Wound Infection Deep Incisional Surgical Site

Interventions

DRUG

Photodynamic Therapy

PDT with methyl aminolevulinate (MAL) as the prodrug for the photosensitizer Pp IX

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Yvonne Achermann, PD Dr. med. · Dermatology

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-04
Primary Completion
2023-09-01
Completion
2023-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05676801 on ClinicalTrials.gov